Company page
Krystal Biotech, Inc.
Krystal Biotech, Inc. is a public company traded under the ticker KRYS in the American market. The company has a market capitalization of approximately $10.26 billion. Krystal Biotech focuses on developing innovative gene therapies for various dermatological conditions.
- Ticker
- KRYS:NASDAQ
- Asset type
- Stock
- Market cap
- $10.26B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD